Medical device company ShockWave Medical, Inc. is making waves with its intravascular lithotripsy (IVL) technology, which treats calcified plaque in patients suffering from peripheral and coronary vascular, and heart valve diseases both domestically and abroad. The company's suite of products designed specifically for peripheral artery disease (PAD) includes the M5 IVL catheter, the M5+ IVL catheter, the S4 IVL catheter, and the L6 IVL catheter, which all function within the IVL system range of medium to large diameter vessels. For the treatment of coronary artery disease, ShockWave offers the C2 IVL catheter and C2+IVL catheter, both functioning as two-emitter catheters within the IVL system. Its customer base includes vascular surgeons, interventional radiologists, and interventional cardiologists, with sales being facilitated by representatives, managers, and distributors. Founded in 2009, ShockWave Medical, Inc. is headquartered in Santa Clara, California.